Project description DEENESFRITPL Better surgical safety in a pandemic Viral aerosols are a critical risk for surgical teams in the time of COVID-19. Invisible viral aerosols are released by leaks around the trocars used in laparascopic surgery, and in patient breath/coughing during endoscopy. Unless these risks are addressed, normal surgical service is blocked across the health services. The PORSAV project uses innovative Schlieren imaging to capture and analyse data about aerosols and their distribution in the operating room. It introduces novel vacuum-driven medical devices to capture aerosols at the points of leakage, thus avoiding contamination of the operating room. Following clinical validation, the project delivers training to surgeons and distribution of the new technology, globally. Show the project objective Hide the project objective Objective Protecting healthcare staff and preserving key clinical practice is a key WHO priority area for the immediate term in the COVID-19 pandemic, and also after peak crisis in the new practice landscape with population prevalence. Surgery is a key therapy for emergency patients and for cancer care and cardiac disease among others. It also is the hallmark aerosolising intervention, risking viral transmission to many staff, not only during the procedure itself, but also during other interventional procedures including bedside episodic procedures such as intubation for ventilation or nasogastric tube drainage. Recent guidance has suggested abandoning keyhole surgery access, despite its cornerstone role in emergency and cancer therapy, its myriad benefits to patients, and the fact that a whole generation of surgeons would need retraining in open surgery to accomplish this safely. Laparoscopic surgery uses gas to distend a body cavity to make space for a camera and instruments to be inserted and worked by a surgical team. This gas is emptied from the patient by opening valves in the access instrumentation which typically enters the operating room (OR). The risks of venting gas can be addressed technologically by using more sophisticated and emerging insufflation technology. However this does not address leaks during endotracheal tube placement, leaks that occur around the trocar, leaks during endoscopy or leaks from the anus during transanal surgery. This project will a) characterise the nature of these gas leaks using specialized imaging technology, b) develop vacuum devices to entrain and filter such leaks c) validate the effectiveness of the devices clinically, complete CE mark certification and e) deploy to surgery centres worldwide. Fields of science medical and health sciencesclinical medicinesurgerysurgical specialtiesengineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsoptical sensorsmedical and health scienceshealth sciencespublic healthepidemiologypandemicsmedical and health scienceshealth sciencesinfectious diseasesRNA virusescoronavirusesmedical and health sciencesclinical medicineoncology Programme(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme Topic(s) SC1-PHE-CORONAVIRUS-2020-2B - Medical technologies, Digital tools and Artificial Intelligence (AI) analytics to improve surveillance and care at high Technology Readiness Levels (TRL) Call for proposal H2020-SC1-PHE-CORONAVIRUS-2020-2 See other projects for this call Sub call H2020-SC1-PHE-CORONAVIRUS-2020-2-CNECT Funding Scheme IA - Innovation action Coordinator PINTAIL LTD Net EU contribution € 108 500,00 Address Springhill avenue 77 A94 K542 Blackrock Ireland See on map Region Ireland Eastern and Midland Dublin Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 46 500,00 Participants (4) Sort alphabetically Sort by Net EU contribution Expand all Collapse all PALLIARE LIMITED Ireland Net EU contribution € 924 525,00 Address 2 grand canal square D02 A342 Dublin See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Ireland Eastern and Midland Dublin Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 396 225,00 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN Ireland Net EU contribution € 461 360,00 Address Belfield 4 Dublin See on map Region Ireland Eastern and Midland Dublin Activity type Higher or Secondary Education Establishments Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 0,00 INSTITUT DE RECHERCHE CONTRE LES CANCERS DE L'APPAREIL DIGESTIF France Net EU contribution € 448 740,00 Address Place de l'hopital 1 67091 Strasbourg cedex See on map Region Grand Est Alsace Bas-Rhin Activity type Research Organisations Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 0,00 STERIPACK MEDICAL POLAND SP ZOO Poland Net EU contribution € 295 575,00 Address Ul. japonska 1 leg 55 220 Jelcz laskowice See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Makroregion południowo-zachodni Dolnośląskie Wrocławski Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 126 676,25
